Merck Issues Voluntary Nationwide Recall of CUBICIN® (Daptomycin for Injection) 500 mg, Lot 934778, Due to Presence of Particulate Matter Identified as Glass Particles

Date: 10/20/2021

Product type: Drugs, Potential Foreign Material

Company Announcement Date: October 19, 2021
FDA Publish Date: October 20, 2021
Product Type: Drugs
Reason for Announcement: Product contains particulate matter identified as glass
Company Name: Merck
Brand Name: CUBICIN
Product Description: Daptomycin for injection 500mg

US-FSA Link: